Turnstone Biologics Corp. Operating Expenses
Turnstone Biologics Corp. reported Operating Expenses of $5.56 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2025-08-08
- Turnstone Biologics Corp. operating expenses for the quarter ending 2025-06-30 was $5.56M, a 74.80% decline year-over-year.
- Turnstone Biologics Corp. operating expenses for the quarter ending 2025-03-31 was $9.16M, a 55.71% decline year-over-year.
- Turnstone Biologics Corp. operating expenses for the quarter ending 2024-12-31 was $11.38M, a 36.28% decline year-over-year.
- Turnstone Biologics Corp. operating expenses for the quarter ending 2024-09-30 was $18.37M, a 2.97% decline year-over-year.
- Turnstone Biologics Corp. operating expenses for fiscal 2024 was $72.49M, a 7.46% decline from fiscal 2023.
- Turnstone Biologics Corp. operating expenses for fiscal 2023 was $78.34M, a 25.34% decline from fiscal 2022.
- Turnstone Biologics Corp. operating expenses for fiscal 2022 was $104.93M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2025-06-30 | $5.56M 10-Q · filed 2025-08-08 | $14.72M 10-Q · filed 2025-08-08 | $26.10M derived: sum of 3 quarters · filed 2025-08-08 | $44.47M derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | $9.16M 10-Q · filed 2025-05-09 | $20.54M derived: sum of 2 quarters · filed 2025-05-09 | $38.91M derived: sum of 3 quarters · filed 2025-05-09 | $60.97M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-12-31 | $11.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $29.75M derived: sum of 2 quarters · filed 2025-03-31 | $51.80M derived: sum of 3 quarters · filed 2025-08-08 | $72.49M 10-K · filed 2025-03-31 |
| 2024-09-30 | $18.37M 10-Q · filed 2024-11-12 | $40.42M derived: sum of 2 quarters · filed 2025-08-08 | $61.12M 10-Q · filed 2024-11-12 | $78.97M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-06-30 | $22.06M 10-Q · filed 2025-08-08 | $42.75M 10-Q · filed 2025-08-08 | $60.60M derived: sum of 3 quarters · filed 2025-08-08 | $79.53M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $20.69M 10-Q · filed 2025-05-09 | $38.55M derived: sum of 2 quarters · filed 2025-05-09 | $57.48M derived: sum of 3 quarters · filed 2025-05-09 | $79.33M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $17.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $36.79M derived: sum of 2 quarters · filed 2025-03-31 | $58.64M derived: sum of 3 quarters · filed 2025-03-31 | $78.34M 10-K · filed 2025-03-31 |
| 2023-09-30 | $18.93M 10-Q · filed 2024-11-12 | $40.78M derived: sum of 2 quarters · filed 2024-11-12 | $60.48M 10-Q · filed 2024-11-12 | $85.05M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $21.85M 10-Q · filed 2024-08-14 | $41.55M 10-Q · filed 2024-08-14 | $66.12M derived: sum of 3 quarters · filed 2024-08-14 | $92.61M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $19.70M 10-Q · filed 2024-05-13 | $44.27M derived: sum of 2 quarters · filed 2024-05-13 | $70.76M derived: sum of 3 quarters · filed 2024-05-13 | $101.23M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $24.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $51.06M derived: sum of 2 quarters · filed 2024-03-22 | $81.53M derived: sum of 3 quarters · filed 2024-03-22 | $104.93M 10-K · filed 2024-03-22 |
| 2022-09-30 | $26.49M 10-Q · filed 2023-11-13 | $56.96M derived: sum of 2 quarters · filed 2023-11-13 | $80.36M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $30.47M 10-Q · filed 2023-09-01 | $53.87M 10-Q · filed 2023-09-01 |